Marshall Wace, LLP Kura Oncology, Inc. Transaction History

Marshall Wace, LLP

  • $74.4 Billion
  • Q1 2025

A detailed history of Marshall Wace, LLP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 392,049 shares of KURA stock, worth $2.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
392,049
Previous 948,905 58.68%
Holding current value
$2.58 Million
Previous $8.26 Million 68.7%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$6.6 - $9.05 $3.68 Million - $5.04 Million
-556,856 Reduced 58.68%
392,049 $2.59 Million
Q4 2024

Feb 13, 2025
BUY
$8.51 - $19.21 $8.08 Million - $18.2 Million
948,905 New
948,905 $8.26 Million
Q2 2024

Aug 14, 2024
BUY
$17.53 - $22.98 $460,460 - $603,615
26,267 New
26,267 $540,000
Q2 2023

Aug 14, 2023
BUY
$9.62 - $13.99 $769,638 - $1.12 Million
80,004 New
80,004 $846,000
Q1 2021

May 17, 2021
SELL
$24.75 - $39.14 $2.77 Million - $4.38 Million
-111,936 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$29.0 - $41.62 $3.25 Million - $4.66 Million
111,936 New
111,936 $3.66 Million
Q3 2020

Nov 16, 2020
SELL
$16.3 - $30.64 $225,836 - $424,517
-13,855 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$7.95 - $18.81 $110,147 - $260,612
13,855 New
13,855 $225,000
Q4 2019

Feb 14, 2020
SELL
$12.97 - $15.94 $495,246 - $608,652
-38,184 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$14.75 - $20.87 $4.57 Million - $6.46 Million
-309,514 Reduced 89.02%
38,184 $579,000
Q2 2019

Aug 14, 2019
BUY
$14.71 - $19.79 $4.78 Million - $6.44 Million
325,258 Added 1449.46%
347,698 $6.85 Million
Q1 2019

May 14, 2019
BUY
$13.73 - $16.87 $308,101 - $378,562
22,440 New
22,440 $372,000
Q2 2018

Aug 14, 2018
SELL
$14.8 - $18.8 $162,800 - $206,800
-11,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$14.5 - $23.4 $159,500 - $257,399
11,000 New
11,000 $206,000

Others Institutions Holding KURA

# of Institutions
190
Shares Held
79M
Call Options Held
76K
Put Options Held
85.8K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $439M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email